logo
GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
x 4: Reconciliation of FY 2025 of Core EBITDA to IFRS Net Income






In million USD



FY 2024



FY2025





Core EBITDA



1,031



1,211





% margin



23.4%



23.3%





Exceptional and transformation related adjustments



(60)



(16)





Other income / (expenses) excl. impairment



(33)



(43)





Total EBITDA adjustments8


=*=*=*=*=*=
当前为第37/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页